(Q40342191)

19 September 2017

Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs (English)

1 reference

19 September 2017

Sergio Carmona

1

1 reference

19 September 2017

Abdullah Ely

2

1 reference

19 September 2017

Carol Crowther

3

1 reference

19 September 2017

Naazneen Moolla

4

1 reference

19 September 2017

Felix H Salazar

5

1 reference

19 September 2017

Patricia L Marion

6

1 reference

19 September 2017

Nicolas Ferry

7

1 reference

19 September 2017

Marc S Weinberg

8

1 reference

19 September 2017

Patrick Arbuthnot

9

1 reference

19 September 2017

5 December 2005

1 reference

19 September 2017

1 reference

19 September 2017

13

1 reference

19 September 2017

2

1 reference

19 September 2017

411-421

1 reference

Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Hepatocellular Carcinoma and Hepatitis B Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Prevalence of hepatitis B "e" antigen and its antibody in various HBsAg carrier populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Hepatitis B virus genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Hepatitis B virus: significance of genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Antiviral therapy for chronic hepatitis B: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

7 January 2021

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

7 January 2021

RNA interference--2001.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

A system for stable expression of short interfering RNAs in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

RNA interference is mediated by 21- and 22-nucleotide RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Inhibition of hepatitis B virus replication by stably expressed shRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Small interfering RNA Inhibits Hepatitis B virus replication in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Short interfering RNA-directed inhibition of hepatitis B virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Inhibition of HBV replication by siRNA in a stable HBV-producing cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Inhibition of hepatitis B virus in mice by RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Inhibition of hepatitis B virus expression and replication by RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Selective inhibition of hepatitis B virus replication by RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Gene discovery by ribozyme and siRNA libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Analysis of double-stranded RNA-induced apoptosis pathways using interferon-response noninducible small interfering RNA expression vector library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Induction of an interferon response by RNAi vectors in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Activation of the interferon system by short-interfering RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Functional siRNAs and miRNAs Exhibit Strand Bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Rational siRNA design for RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Asymmetry in the assembly of the RNAi enzyme complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Functional siRNA expression from transfected PCR products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Platelet-derived growth factor alpha receptor gene expression: isolation and characterization of the promoter and upstream regulatory elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2005.10.013

1 reference

19 September 2017

1 reference